About
Development of regenerative biologic matrices
Areas of Focus
Categories
Biologics & BiopharmaceuticalBoston & New England
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
173
By Phase
PHASE1/PHASE2: 1EARLY_PHASE1: 1PHASE4: 1
By Status
RECRUITING: 2COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06730828Lead Sponsor
Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects
PHASE1/PHASE2Recruiting
80 participants
Started: Dec 16, 2024 · Completed: May 31, 2026
NCT06063538Collaborator
Prevention of Postoperative Atrial Fibrillation (POAF) Using Intra-Pericardial Amiodarone
EARLY_PHASE1Recruiting
63 participants
Started: Feb 15, 2024 · Completed: Jun 30, 2027
NCT05681182Collaborator
Prevention of Post-OP AFib Using Combination of CardiaMend and Amiodarone
PHASE4Completed
30 participants
Started: Jan 20, 2023 · Completed: Feb 6, 2024
Locations (1)
Headquarters
Weston, MA, United States
Map
Loading map...